$29.09
-0.01-0.03%
At Close: -
$29.09
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Immunovant (NASDAQ:IMVT) Stock, Insider Trading Activity
Immunovant: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Immunovant Inc Insiders Doing?
At Immunovant Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 41.40K shares worth $1.19M, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On July 10, 2024, Julia G Butchko, the company's CHIEF DEVELOPMENT OFFICER sold 1.53K shares for $28.06 each.
- On July 19, 2024, Mark S Levine, the company's CHIEF LEGAL OFFICER sold 2.51K shares for $29.69 each.
- On July 26, 2024, Jay S Stout, the company's CHIEF TECHNOLOGY OFFICER sold 2.81K shares for $27.76 each.
Ownership Statistics for Immunovant Inc
Institutional Shares Held
39.860M
Institutional Percentage Held
27.3%
| Jul 26, 2024 | Jay S Stout | CHIEF TECHNOLOGY OFFICER | -2.81K | $27.76 | -$78.09K | SELL | -1.90% | 144.93K | Jul 24 | View |
| Jul 26, 2024 | Michael Geffner | CHIEF MEDICAL OFFICER | -3.46K | $27.76 | -$95.94K | SELL | -2.44% | 138.16K | Jul 24 | View |
| Jul 26, 2024 | Mark S Levine | CHIEF LEGAL OFFICER | -4.01K | $27.76 | -$111.46K | SELL | -1.19% | 333.39K | Jul 24 | View |
| Jul 19, 2024 | Mark S Levine | CHIEF LEGAL OFFICER | -2.50K | $29.69 | -$74.38K | SELL | -0.74% | 337.41K | Jul 17 | View |
| Jul 19, 2024 | William L Macias | CHIEF MEDICAL OFFICER | -3.04K | $29.69 | -$90.39K | SELL | -0.81% | 371.36K | Jul 17 | View |
| Jul 19, 2024 | Eva Renee Barnett | CHIEF FINANCIAL OFFICER | -3.12K | $29.69 | -$92.73K | SELL | -0.89% | 347.54K | Jul 17 | View |
| Jul 19, 2024 | Julia G Butchko | CHIEF DEVELOPMENT OFFICER | -2.87K | $29.69 | -$85.13K | SELL | -0.64% | 443.99K | Jul 17 | View |
| Jul 19, 2024 | Peter Salzmann | CHIEF EXECUTIVE OFFICER | -8.69K | $29.69 | -$257.89K | SELL | -0.84% | 1.02M | Jul 17 | View |
| Jul 10, 2024 | Eva Renee Barnett | CHIEF FINANCIAL OFFICER | -4.75K | $28.06 | -$133.20K | SELL | -1.34% | 350.67K | Jul 09 | View |
| Jul 10, 2024 | Julia G Butchko | CHIEF DEVELOPMENT OFFICER | -1.53K | $28.06 | -$42.85K | SELL | -0.34% | 446.85K | Jul 09 | View |
| Jul 10, 2024 | Peter Salzmann | CHIEF EXECUTIVE OFFICER | -4.62K | $28.06 | -$129.61K | SELL | -0.45% | 1.03M | Jul 09 | View |
| May 24, 2024 | Eva Renee Barnett | CHIEF FINANCIAL OFFICER | -4.04K | $29.65 | -$119.85K | SELL | -1.12% | 355.41K | May 22 | View |
| May 24, 2024 | Peter Salzmann | CHIEF EXECUTIVE OFFICER | -16.16K | $29.65 | -$479.23K | SELL | -1.54% | 1.04M | May 22 | View |
| May 24, 2024 | Julia G Butchko | CHIEF DEVELOPMENT OFFICER | -3.25K | $29.65 | -$96.27K | SELL | -0.72% | 448.38K | May 22 | View |
| May 24, 2024 | William L Macias | CHIEF MEDICAL OFFICER | -3.25K | $29.65 | -$96.27K | SELL | -0.86% | 374.40K | May 22 | View |
| May 24, 2024 | Mark S Levine | CHIEF LEGAL OFFICER | -3.24K | $29.65 | -$96.13K | SELL | -0.94% | 339.91K | May 22 | View |
| Apr 26, 2024 | Michael Geffner | CHIEF MEDICAL OFFICER | -3.26K | $28.90 | -$94.24K | SELL | -2.25% | 141.62K | Apr 24 | View |
| Apr 26, 2024 | Jay S Stout | CHIEF TECHNOLOGY OFFICER | -7.24K | $28.90 | -$209.21K | SELL | -4.67% | 147.74K | Apr 24 | View |
| Apr 26, 2024 | Mark S Levine | CHIEF LEGAL OFFICER | -3.96K | $28.90 | -$114.53K | SELL | -1.14% | 343.16K | Apr 24 | View |
| Apr 19, 2024 | Mark S Levine | CHIEF LEGAL OFFICER | -9.83K | $29.06 | -$285.55K | SELL | -2.75% | 347.12K | Apr 17 | View |
| Apr 19, 2024 | William L Macias | CHIEF MEDICAL OFFICER | -8.28K | $29.06 | -$240.60K | SELL | -2.15% | 377.65K | Apr 17 | View |
| Apr 19, 2024 | Eva Renee Barnett | CHIEF FINANCIAL OFFICER | -12.25K | $29.06 | -$356.05K | SELL | -3.30% | 359.46K | Apr 17 | View |
| Apr 19, 2024 | Julia G Butchko | CHIEF DEVELOPMENT OFFICER | -10.12K | $29.06 | -$293.92K | SELL | -2.19% | 451.63K | Apr 17 | View |
| Apr 19, 2024 | Peter Salzmann | CHIEF EXECUTIVE OFFICER | -34.08K | $29.06 | -$990.27K | SELL | -3.14% | 1.05M | Apr 17 | View |
| Apr 10, 2024 | Eva Renee Barnett | CHIEF FINANCIAL OFFICER | -3.69K | $31.18 | -$115.02K | SELL | -0.98% | 371.71K | Apr 09 | View |
| Apr 10, 2024 | Julia G Butchko | CHIEF DEVELOPMENT OFFICER | -1.05K | $31.18 | -$32.83K | SELL | -0.23% | 461.74K | Apr 09 | View |
| Apr 10, 2024 | Peter Salzmann | CHIEF EXECUTIVE OFFICER | -4.81K | $31.18 | -$149.88K | SELL | -0.44% | 1.09M | Apr 09 | View |
| Feb 23, 2024 | Eva Renee Barnett | CHIEF FINANCIAL OFFICER | -2.93K | $36.15 | -$105.92K | SELL | -0.91% | 320.42K | Feb 22 | View |
| Feb 23, 2024 | Mark S Levine | CHIEF LEGAL OFFICER | -2.13K | $36.15 | -$77.14K | SELL | -0.70% | 301.97K | Feb 22 | View |
| Feb 23, 2024 | William L Macias | CHIEF MEDICAL OFFICER | -2.22K | $36.15 | -$80.29K | SELL | -0.67% | 330.95K | Feb 22 | View |
| Feb 23, 2024 | Julia G Butchko | CHIEF DEVELOPMENT OFFICER | -2.15K | $36.15 | -$77.58K | SELL | -0.52% | 407.82K | Feb 22 | View |
| Feb 23, 2024 | Peter Salzmann | CHIEF EXECUTIVE OFFICER | -13.45K | $36.15 | -$486.36K | SELL | -1.42% | 931.23K | Feb 22 | View |
| Jan 29, 2024 | Mark S Levine | CHIEF LEGAL OFFICER | -3.03K | $37.92 | -$114.78K | SELL | -0.99% | 304.10K | Jan 26 | View |
| Jan 29, 2024 | Michael Geffner | CHIEF MEDICAL OFFICER | -10.10K | $37.92 | -$383.01K | SELL | -10.10% | 89.90K | Jan 26 | View |
| Jan 19, 2024 | William L Macias | CHIEF MEDICAL OFFICER | -424.00 | $41.03 | -$17.40K | SELL | -0.13% | 333.17K | Jan 18 | View |
| Jan 12, 2024 | Eva Renee Barnett | CHIEF FINANCIAL OFFICER | -3.52K | $41.83 | -$147.02K | SELL | -1.08% | 323.35K | Jan 11 | View |
| Jan 09, 2024 | Julia G Butchko | CHIEF DEVELOPMENT OFFICER | -1.30K | $38.59 | -$50.05K | SELL | -0.32% | 409.96K | Jan 05 | View |
| Jan 09, 2024 | Peter Salzmann | CHIEF EXECUTIVE OFFICER | -3.82K | $38.59 | -$147.57K | SELL | -0.40% | 944.68K | Jan 05 | View |
| Dec 05, 2023 | Andrew J Fromkin | DIRECTOR | -12.35K | $39.73 | -$490.70K | SELL | -12.23% | 88.66K | Dec 01 | View |
| Dec 05, 2023 | Atul Pande | DIRECTOR | -12.35K | $39.73 | -$490.67K | SELL | -10.69% | 103.16K | Dec 01 | View |
| Dec 05, 2023 | George V Migausky | DIRECTOR | -12.70K | $39.73 | -$504.57K | SELL | -10.37% | 109.81K | Dec 01 | View |
| Nov 24, 2023 | Peter Salzmann | CHIEF EXECUTIVE OFFICER | -16.22K | $32.78 | -$531.58K | SELL | -1.68% | 948.51K | Nov 22 | View |
| Nov 24, 2023 | Eva Renee Barnett | CHIEF FINANCIAL OFFICER | -4.05K | $32.78 | -$132.92K | SELL | -1.23% | 326.87K | Nov 22 | View |
| Nov 24, 2023 | Julia G Butchko | CHIEF DEVELOPMENT OFFICER | -3.27K | $32.78 | -$107.02K | SELL | -0.79% | 411.26K | Nov 22 | View |
| Nov 24, 2023 | William L Macias | CHIEF MEDICAL OFFICER | -3.27K | $32.78 | -$107.02K | SELL | -0.97% | 333.60K | Nov 22 | View |
| Nov 24, 2023 | Mark S Levine | CHIEF LEGAL OFFICER | -3.25K | $32.78 | -$106.60K | SELL | -1.05% | 307.13K | Nov 22 | View |
| Oct 27, 2023 | Mark S Levine | CHIEF LEGAL OFFICER | -4.11K | $34.66 | -$142.35K | SELL | -1.31% | 310.38K | Oct 25 | View |
| Oct 20, 2023 | William L Macias | CHIEF MEDICAL OFFICER | -530.00 | $36.80 | -$19.50K | SELL | -0.16% | 336.86K | Oct 19 | View |
| Oct 11, 2023 | Eva Renee Barnett | CHIEF FINANCIAL OFFICER | -4.56K | $36.92 | -$168.24K | SELL | -1.36% | 330.92K | Oct 10 | View |
| Oct 06, 2023 | Julia G Butchko | CHIEF DEVELOPMENT OFFICER | -1.74K | $36.24 | -$62.89K | SELL | -0.42% | 414.52K | Oct 05 | View |
| Oct 06, 2023 | Peter Salzmann | CHIEF EXECUTIVE OFFICER | -5.24K | $36.24 | -$189.89K | SELL | -0.54% | 964.73K | Oct 05 | View |
| Oct 04, 2023 | Roivant Sciences Ltd | — | 6.00M | $38.00 | $228.00M | BUY | 8.13% | 79.81M | Oct 02 | View |
| Sep 01, 2023 | Peter Salzmann | CHIEF EXECUTIVE OFFICER | -56.77K | $22.02 | -$1.25M | SELL | -5.53% | 969.97K | Aug 30 | View |
| Aug 25, 2023 | Mark S Levine | CHIEF LEGAL OFFICER | -12.29K | $20.30 | -$249.41K | SELL | -3.76% | 314.49K | Aug 24 | View |
| Aug 25, 2023 | Eva Renee Barnett | CHIEF FINANCIAL OFFICER | -14.39K | $20.30 | -$292.04K | SELL | -4.11% | 335.48K | Aug 24 | View |
| Aug 25, 2023 | Julia G Butchko | CHIEF DEVELOPMENT OFFICER | -12.33K | $20.30 | -$250.36K | SELL | -2.88% | 416.26K | Aug 24 | View |
| Aug 25, 2023 | William L Macias | CHIEF MEDICAL OFFICER | -12.33K | $20.30 | -$250.36K | SELL | -3.53% | 337.39K | Aug 24 | View |
| Aug 16, 2023 | Peter Salzmann | CHIEF EXECUTIVE OFFICER | -103.06K | $21.42 | -$2.21M | SELL | -9.12% | 1.03M | Aug 14 | View |
| Aug 08, 2023 | Peter Salzmann | CHIEF EXECUTIVE OFFICER | -101.34K | $21.73 | -$2.20M | SELL | -8.23% | 1.13M | Aug 07 | View |
| Jul 27, 2023 | Mark S Levine | CHIEF LEGAL OFFICER | -3.92K | $21.63 | -$84.72K | SELL | -1.18% | 326.77K | Jul 26 | View |
| Jul 20, 2023 | William L Macias | CHIEF MEDICAL OFFICER | -426.00 | $24.94 | -$10.62K | SELL | -0.12% | 349.73K | Jul 19 | View |
| Jul 20, 2023 | Eva Renee Barnett | CHIEF FINANCIAL OFFICER | -2.73K | $24.94 | -$67.96K | SELL | -0.77% | 349.86K | Jul 19 | View |
| Jul 13, 2023 | Peter Salzmann | CHIEF EXECUTIVE OFFICER | -3.23K | $19.73 | -$63.79K | SELL | -0.26% | 1.23M | Jul 12 | View |
| Jul 13, 2023 | Julia G Butchko | CHIEF DEVELOPMENT OFFICER | -1.47K | $19.73 | -$29.00K | SELL | -0.34% | 428.59K | Jul 12 | View |
| Apr 26, 2023 | William L Macias | CHIEF MEDICAL OFFICER | -509.00 | $16.29 | -$8.29K | SELL | -0.15% | 350.15K | Apr 25 | View |
| Apr 26, 2023 | Mark S Levine | CHIEF LEGAL OFFICER | -2.63K | $16.29 | -$42.89K | SELL | -0.79% | 330.69K | Apr 25 | View |
| Apr 19, 2023 | Eva Renee Barnett | CHIEF FINANCIAL OFFICER | -3.42K | $15.27 | -$52.27K | SELL | -0.96% | 352.59K | Apr 18 | View |
| Apr 19, 2023 | Julia G Butchko | CHIEF DEVELOPMENT OFFICER | -1.54K | $15.27 | -$23.58K | SELL | -0.36% | 430.06K | Apr 18 | View |
| Apr 19, 2023 | Peter Salzmann | CHIEF EXECUTIVE OFFICER | -3.40K | $15.27 | -$51.84K | SELL | -0.27% | 1.23M | Apr 18 | View |
| Feb 03, 2023 | William L Macias | CHIEF MEDICAL OFFICER | -537.00 | $18.24 | -$9.79K | SELL | -0.20% | 263.00K | Feb 02 | View |
| Jan 27, 2023 | Mark S Levine | CHIEF LEGAL OFFICER | -10.16K | $18.51 | -$187.99K | SELL | -3.97% | 245.66K | Jan 26 | View |
| Jan 13, 2023 | Peter Salzmann | CHIEF EXECUTIVE OFFICER | -4.02K | $16.80 | -$67.55K | SELL | -0.40% | 993.93K | Jan 11 | View |
| Jan 13, 2023 | Julia G Butchko | CHIEF DEV. & TECH. OFFICER | -60.49K | $16.79 | -$1.02M | SELL | -15.43% | 331.42K | Jan 11 | View |
| Jan 13, 2023 | Eva Renee Barnett | CHIEF FINANCIAL OFFICER | -4.51K | $16.75 | -$75.52K | SELL | -1.65% | 268.35K | Jan 11 | View |
| Jan 13, 2023 | William L Macias | CHIEF MEDICAL OFFICER | -44.57K | $16.75 | -$746.32K | SELL | -14.47% | 263.53K | Jan 11 | View |
| Oct 25, 2022 | William L Macias | CHIEF MEDICAL OFFICER | -341.00 | $9.67 | -$3.30K | SELL | -0.11% | 308.10K | Oct 21 | View |
| Oct 17, 2022 | Julia G Butchko | CHIEF DEV. & TECH. OFFICER | -928.00 | $9.18 | -$8.52K | SELL | -0.24% | 391.91K | Oct 13 | View |
| Oct 17, 2022 | Peter Salzmann | CHIEF EXECUTIVE OFFICER | -2.79K | $9.18 | -$25.64K | SELL | -0.28% | 997.95K | Oct 13 | View |
| Oct 13, 2022 | Eva Renee Barnett | CHIEF FINANCIAL OFFICER | -12.50K | $9.44 | -$118.00K | SELL | -4.38% | 272.86K | Oct 11 | View |
| Oct 07, 2022 | Roivant Sciences Ltd | — | 416.67K | $6.00 | $2.50M | BUY | 0.57% | 73.81M | Oct 06 | View |
| Oct 04, 2022 | Atul Pande | DIRECTOR | 15.00K | $5.60 | $84.00K | BUY | 17.05% | 102.98K | Sep 30 | View |
| Sep 29, 2022 | Julia G Butchko | CHIEF DEV. & TECH. OFFICER | -535.00 | $4.67 | -$2.50K | SELL | -0.14% | 392.84K | Sep 28 | View |
| Sep 29, 2022 | Peter Salzmann | CHIEF EXECUTIVE OFFICER | -1.60K | $4.67 | -$7.50K | SELL | -0.16% | 1.00M | Sep 28 | View |
| Sep 29, 2022 | Frank Torti | DIRECTOR | 20.00K | $5.81 | $116.20K | BUY | 5.36% | 393.36K | Sep 29 | View |
| Sep 01, 2022 | Peter Salzmann | CHIEF EXECUTIVE OFFICER | -1.64K | $5.83 | -$9.58K | SELL | -0.16% | 1.00M | Aug 30 | View |
| Sep 01, 2022 | Julia G Butchko | CHIEF DEV. & TECH. OFFICER | -548.00 | $5.83 | -$3.19K | SELL | -0.14% | 393.37K | Aug 30 | View |
| Jul 29, 2022 | Julia G Butchko | CHIEF DEV. & TECH. OFFICER | -510.00 | $4.27 | -$2.18K | SELL | -0.18% | 281.10K | Jul 27 | View |
| Jul 29, 2022 | Peter Salzmann | CHIEF EXECUTIVE OFFICER | -1.53K | $4.27 | -$6.52K | SELL | -0.28% | 552.73K | Jul 27 | View |
| Jul 26, 2022 | William L Macias | CHIEF MEDICAL OFFICER | -322.00 | $4.70 | -$1.51K | SELL | -0.16% | 195.63K | Jul 22 | View |
| Jul 01, 2022 | Peter Salzmann | CHIEF EXECUTIVE OFFICER | -1.38K | $4.02 | -$5.53K | SELL | -0.25% | 554.26K | Jun 29 | View |
| Jul 01, 2022 | Julia G Butchko | CHIEF DEV. & TECH. OFFICER | -460.00 | $4.02 | -$1.85K | SELL | -0.16% | 281.61K | Jun 29 | View |
| May 25, 2022 | Julia G Butchko | CHIEF DEV. & TECH. OFFICER | -492.00 | $3.79 | -$1.86K | SELL | -0.17% | 282.07K | May 24 | View |
| May 25, 2022 | Peter Salzmann | CHIEF EXECUTIVE OFFICER | -1.47K | $3.79 | -$5.58K | SELL | -0.26% | 555.63K | May 24 | View |
| Apr 29, 2022 | Julia G Butchko | CHIEF DEV. & TECH. OFFICER | -541.00 | $4.72 | -$2.55K | SELL | -0.19% | 282.57K | Apr 27 | View |
| Apr 29, 2022 | Peter Salzmann | CHIEF EXECUTIVE OFFICER | -1.62K | $4.72 | -$7.66K | SELL | -0.29% | 557.11K | Apr 27 | View |
| Apr 20, 2022 | William L Macias | CHIEF MEDICAL OFFICER | -1.39K | $4.98 | -$6.93K | SELL | -0.71% | 195.95K | Apr 19 | View |
| Apr 14, 2022 | Julia G Butchko | CHIEF DEV. & TECH. OFFICER | -6.38K | $5.90 | -$37.65K | SELL | -2.20% | 283.11K | Mar 24 | View |
| Apr 14, 2022 | Peter Salzmann | CHIEF EXECUTIVE OFFICER | -19.23K | $5.90 | -$113.44K | SELL | -3.33% | 558.73K | Mar 24 | View |
| Jan 11, 2022 | Julia G Butchko | CHIEF DEV. & TECH. OFFICER | -55.32K | $7.25 | -$401.06K | SELL | -16.04% | 289.49K | Jan 07 | View |
| Jan 11, 2022 | Eva Renee Barnett | CHIEF FINANCIAL OFFICER | -29.96K | $7.25 | -$217.20K | SELL | -14.79% | 172.54K | Jan 07 | View |
| Jan 11, 2022 | Peter Salzmann | CHIEF EXECUTIVE OFFICER | -125.16K | $7.25 | -$907.40K | SELL | -17.80% | 577.96K | Jan 07 | View |
| Jan 07, 2022 | William L Macias | CHIEF MEDICAL OFFICER | -26.81K | $8.28 | -$222.01K | SELL | -11.96% | 197.34K | Jan 05 | View |
| Aug 30, 2021 | Douglas J Hughes | DIRECTOR | 18.25K | $8.24 | $150.36K | BUY | 45.39% | 58.45K | Aug 27 | View |
| Aug 20, 2021 | George V Migausky | DIRECTOR | 7.00K | $7.65 | $53.55K | BUY | 11.63% | 67.20K | Aug 20 | View |
| Aug 16, 2021 | Atul Pande | DIRECTOR | 5.00K | $7.98 | $39.90K | BUY | 12.44% | 45.20K | Aug 13 | View |
| Aug 11, 2021 | Andrew J Fromkin | DIRECTOR | 5.50K | $7.90 | $43.45K | BUY | 13.68% | 45.70K | Aug 10 | View |
| Sep 15, 2020 | Julia G Butchko | — | 5.00K | $38.17 | $190.85K | PURCHASE | ∞ | 5.00K | Sep 11 | View |
| Sep 04, 2020 | Roivant Sciences Ltd | — | 380.00K | $33.00 | $12.54M | PURCHASE | 0.80% | 47.59M | Sep 04 | View |
| Apr 17, 2020 | Roivant Sciences Ltd | — | 1.03M | $14.50 | $15.00M | PURCHASE | 2.77% | 38.44M | Apr 16 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
IMVT Insider Trading News
No news found